We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in China
Price data last checked 53 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 38 days • 38 data points (No recent data available)
Price Distribution
Price distribution over 38 days • 1 price levels
Price Analysis
Most common price: £495 (38 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 38 days
Product Specifications
- Format
- paperback
- ASIN
- B0BBJMBF75
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 16 August 2022
- Listed Since
- 25 August 2022
Similar Products You Might Like
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in Japan
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs for US Zip Codes
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in the United States
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in India
The 2013-2018 Outlook for Anti-Hypertensive Drugs in India
The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics
The 2021-2026 World Outlook for Antihypertensive Drugs
The 2016-2021 World Outlook for Anti-Hypertensive Drugs
The 2013-2018 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in India
The 2016-2021 Outlook for Ace Inhibitor Vasodilator Pharmaceuticals in Japan
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in China
The 2021-2026 World Outlook for Ace Inhibitor Vasodilator Pharmaceuticals
The 2016-2021 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in Greater China
The 2016-2021 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in Japan
The 2021-2026 World Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in Japan
The 2013-2018 Outlook for Coronary Vasodilator Pharmaceuticals in India
The 2016-2021 Outlook for Coronary Vasodilator Pharmaceuticals in Greater China
The 2025-2030 World Outlook for Hypertension Management Devices
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in India
The 2013-2018 Outlook for Anti-Arrhythmic Vasodilator Pharmaceuticals in India
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in the United States
The 2016-2021 Outlook for Coronary Vasodilator Pharmaceuticals in Japan
